Therapeutic Uses
Hypertension. Most patients with hypertension, of which 90-95% have
hypertension of unknown origin (primary or essential hypertension), are
effectively treated with diuretics. Antihypertensive therapy with diuretics is
particularly effective when coupled with reduced dietary sodium intake. The
efficacy of these drugs is derived from their ability to reduce blood volume,
cardiac output, and with long-term therapy, systemic vascular resistance. The
vast majority of hypertensive patients are treated with thiazide diuretics.
Potassium-sparing, aldosterone-blocking diuretics (e.g., spironolactone) are
used in secondary hypertension caused by hyperaldosteronism, and sometimes as an
adjunct to thiazide treatment in primary hypertension to prevent hypokalemia.
Heart failure. Heart failure leads to activation of the
renin-angiotensin-aldosterone system, which causes increased sodium and water
retention by the kidneys. This in turn increases blood volume and contributes to
the elevated venous pressures associated with heart failure, which can lead to
pulmonary and systemic edema. The primary use for diuretics in heart failure is
to reduce pulmonary and/or systemic congestion and edema, and associated
clinical symptoms (e.g., shortness of breath - dyspnea). Long-term treatment
with diuretics may also reduce the afterload on the heart by promoting systemic
vasodilation, which can lead to improved ventricular ejection.
When
treating heart failure with diuretics, care must be taken to not unload too much
volume because this can depress cardiac output. For example, if
pulmonary capillary
wedge pressure is 25 mmHg (point A in figure) and pulmonary congestion is
present, a diuretic can safely reduce that elevated pressure to a level (e.g.,
14 mmHg; point B in figure) that will reduce pulmonary pressures without
compromising ventricular stroke volume. The reason for this is that heart
failure caused by
systolic dysfunction is associated with a depressed, flattened
Frank-Starling curve. However, if the volume is reduced too much, stroke volume
will fall because the heart will now be operating on the ascending limb of the
Frank-Starling relationship. If the heart failure is caused by
diastolic
dysfunction, diuretics must be used very carefully so as to not impair
ventricular filling. In diastolic dysfunction, ventricular filling requires
elevated filling pressures because of the reduced
ventricular
compliance.
Most patients in heart failure are prescribed a loop diuretic because they
are more effective in unloading sodium and water than thiazide diuretics. In
mild heart failure, a thiazide diuretic may be used. Potassium-sparing,
aldosterone-blocking diuretics (e.g., spironolactone) are being used
increasingly in heart failure.
Pulmonary and systemic edema. Capillary hydrostatic
pressure and therefore capillary fluid filtration is strongly influenced by
venous pressure Therefore, diuretics, by reducing blood volume and venous
pressure, lower capillary hydrostatic pressure, which reduces net capillary
fluid filtration and tissue edema.
Specific Drugs
Specific drugs comprising the five class of diuretics are listed in the
following table.
Class |
Specific Drugs |
Comments |
Thiazide |
chlorothiazide |
|
|
chlorthalidone |
thiazide-like in action, not
structure |
|
hydrochlorothiazide |
prototypical drug; |
|
hydroflumethiazide |
|
|
indapamide |
thiazide-like in action, not
structure |
|
methyclothiazide |
|
|
metolazone |
thiazide-like in action, not
structure |
|
polythiazide |
|
|
|
|
Loop |
bumetanide |
|
|
ethacrynic acid |
i.v. only |
|
furosemide |
oral and i.v. |
|
torsemide |
|
|
|
|
K+-sparing |
amioloride |
distal tubule Na+-channel
inhibitor |
|
eplerenone |
aldosterone receptor antagonist;
fewer side effects than spironolactone |
|
spironolactone |
aldosterone receptor antagonist; side
effect: gynecomastia |
|
triamterene |
distal tubule Na+-channel
inhibitor |
|
|
|
CA
inhibitors |
acetazolamide |
prototypical drug; not used in
treating hypertension or heart failure |
|
dichlorphenamide |
not used in treating hypertension or
heart failure |
|
methazolamide |
not used in treating hypertension or
heart failure |
Adverse Side Effects and Contraindications
The most important and frequent problem with thiazide and loop diuretics is
hypokalemia. This sometimes requires treatment with potassium supplements or
with a potassium-sparing diuretic. A potentially serious side effect of
potassium-sparing diuretics is hyperkalemia. Other side effects and drug
interactions are list below:
Class |
Adverse Side Effects |
Drug Interactions |
Thiazide
|
�
hypokalemia
�
metabolic alkalosis
�
dehydration (hypovolemia), leading to hypotension
�
hyponatremia
�
hyperglycemia in diabetics
�
hypercholesterolemia; hypertriglyceridemia
�
increased low-density lipoproteins
�
hyperuricemia (at low doses)
�
azotemia (in renal disease patients)
|
�
hypokalemia potentiates digitalis toxicity
�
non-steroidal anti-inflammatory drugs: reduced diuretic
efficacy
�
beta-blockers: potentiate hyperglycemia, hyperlipidemias
�
corticosteroids: enhance hypokalemia |
Loop |
�
hypokalemia
�
metabolic alkalosis
�
hypomagnesemia
�
hyperuricemia
�
dehydration (hypovolemia), leading to hypotension
�
dose-related hearing loss (ototoxicity)
|
�
hypokalemia potentiates digitalis toxicity
�
non-steroidal anti-inflammatory drugs: reduced diuretic
efficacy
�
corticosteroids: enhance hypokalemia
�
aminoglycosides: enhance ototoxicity, nephrotoxicity |
K+-sparing |
�
hyperkalemia
�
metabolic acidosis
�
gynecomastia (aldosterone antagonists)
�
gastric problems including peptic ulcer |
�
ACE inhibitors: potentiate hyperkalemia
�
non-steroidal anti-inflammatory drugs: reduced diuretic
efficacy |
Carbonic
anhydrase inhibitors |
�
hypokalemia
�
metabolic acidosis
|
|
|